Elite Pharmaceuticals (ELTP) Short term Debt (2011 - 2026)
Elite Pharmaceuticals' Short term Debt came in at $135,822 for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 7.9% from $125,822 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Short term Debt (2011 - 2026) Analysis & Trends
Going back to fiscal Q4 2011, Elite Pharmaceuticals' Short term Debt data covers 62 quarters.
- Short term Debt carries a five-year compound annual growth rate of -15.5% (FY2021 to FY2026).
- Going back by fiscal year, Short term Debt was $125,822 in FY2025 (-30.3%), $180,399 in FY2024 (-9.8%), $200,032 in FY2023 (-20.9%) and $253,006 in FY2022 (-19.7%).
- The five-year range for quarterly Short term Debt is $115,000 (fiscal Q1 2023) to $410,386 (fiscal Q2 2022).
- Year-over-year, Short term Debt increased in three of the last eight quarters, with an average decline of 14.3%.
- The fastest year-over-year change in Short term Debt over five years came in fiscal Q1 2025 (growth of 123.4%), and the weakest in fiscal Q1 2023 (a decline of 76.4%).
- Business Quant data shows ELTP's Short term Debt at $135,822 (Q4 2026), $135,822 (Q3 2026) and $135,822 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 229,726.00 |
| Mar 31, 2026 | 228,596.00 |
| Dec 31, 2025 | 227,502.00 |
| Sep 30, 2025 | 231,351.00 |
| Jun 30, 2025 | 230,621.00 |
| Mar 31, 2025 | 246,566.00 |
| Dec 31, 2024 | 289,999.00 |
| Sep 30, 2024 | 367,880.00 |
| Jun 30, 2024 | 429,608.00 |
| Mar 31, 2024 | 296,221.00 |
| Dec 31, 2023 | 306,429.00 |
| Sep 30, 2023 | 295,147.00 |
| Jun 30, 2023 | 251,276.00 |
| Mar 31, 2023 | 310,854.00 |
| Dec 31, 2022 | 471,438.00 |
| Sep 30, 2022 | 502,601.00 |
| Jun 30, 2022 | 115,000.00 |
| Mar 31, 2022 | 353,828.00 |
| Dec 31, 2021 | 400,423.00 |
| Sep 30, 2021 | 511,208.00 |
API Access
Elite Pharmaceuticals Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();